Ş Kirazlı

1.1k total citations
29 papers, 806 citations indexed

About

Ş Kirazlı is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ş Kirazlı has authored 29 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Ş Kirazlı's work include Platelet Disorders and Treatments (11 papers), Blood properties and coagulation (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Ş Kirazlı is often cited by papers focused on Platelet Disorders and Treatments (11 papers), Blood properties and coagulation (6 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). Ş Kirazlı collaborates with scholars based in Türkiye. Ş Kirazlı's co-authors include İbrahim C. Haznedaroğlu, Hakan Göker, Ümit Akman, Yusuf Öztürk, İ. Çelik, Nilgün Sayınalp, İhsan Ertenli, Sedat Kiraz, Meral Çalgünerı and Ö Özdemir and has published in prestigious journals such as Diabetes Care, Annals of Oncology and Atherosclerosis.

In The Last Decade

Ş Kirazlı

29 papers receiving 766 citations

Peers

Ş Kirazlı
Ş Kirazlı
Citations per year, relative to Ş Kirazlı Ş Kirazlı (= 1×) peers Mehmet Ali Özcan

Countries citing papers authored by Ş Kirazlı

Since Specialization
Citations

This map shows the geographic impact of Ş Kirazlı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ş Kirazlı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ş Kirazlı more than expected).

Fields of papers citing papers by Ş Kirazlı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ş Kirazlı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ş Kirazlı. The network helps show where Ş Kirazlı may publish in the future.

Co-authorship network of co-authors of Ş Kirazlı

This figure shows the co-authorship network connecting the top 25 collaborators of Ş Kirazlı. A scholar is included among the top collaborators of Ş Kirazlı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ş Kirazlı. Ş Kirazlı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özyılkan, Özgür, et al.. (2009). CA 15-3, Ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer. East African Medical Journal. 77(6). 291–4. 2 indexed citations
2.
Göker, Hakan, et al.. (2008). Haemostatic Actions of the Folkloric Medicinal Plant Extract Ankaferd Blood Stopper®. Journal of International Medical Research. 36(1). 163–170. 233 indexed citations
3.
Birdane, Alparslan, İbrahim C. Haznedaroğlu, Nüket Bavbek, et al.. (2005). The Plasma Levels of Prostanoids and Plasminogen Activator Inhibitor-1 in Primary and Secondary Thrombocytosis. Clinical and Applied Thrombosis/Hemostasis. 11(2). 197–201. 11 indexed citations
4.
Sayınalp, Nilgün, İbrahim C. Haznedaroğlu, Yahya Büyükaşık, et al.. (2004). Protein C Inhibitor and Serum Amyloid a in Immune Thrombocytopaenic Purpura. Journal of International Medical Research. 32(1). 62–65. 4 indexed citations
5.
Erman, Mustafa, Bülent Oran, İbrahim C. Haznedaroğlu, et al.. (2004). Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?. Annals of Oncology. 15(11). 1622–1626. 33 indexed citations
6.
Sayınalp, Nilgün, İbrahim C. Haznedaroğlu, Salih Aksu, et al.. (2004). The Predictability of Factor V Leiden (FV:Q506) Gene Mutation via Clotting-Based Diagnosis of Activated Protein C Resistance. Clinical and Applied Thrombosis/Hemostasis. 10(3). 265–270. 7 indexed citations
7.
Büyükaşık, Yahya, Sema Karakuş, Hakan Göker, et al.. (2002). Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagulation & Fibrinolysis. 13(4). 349–353. 34 indexed citations
8.
Kiraz, Sedat, İhsan Ertenli, İbrahim C. Haznedaroğlu, et al.. (2002). Bloodstream Thrombopoietin in Rheumatoid Arthritis with Thrombocytosis. Clinical Rheumatology. 21(6). 453–456. 10 indexed citations
9.
Ertenli, İhsan, Sedat Kiraz, Meral Çalgünerı, et al.. (2002). Synovial fluid cytokine levels in Behçet's disease.. PubMed. 19(5 Suppl 24). S37–41. 27 indexed citations
10.
Gürlek, Alper, Miyase Bayraktar, & Ş Kirazlı. (2000). Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.. Diabetes Care. 23(1). 88–92. 32 indexed citations
11.
Koşar, Ali, İbrahim C. Haznedaroğlu, Yaşar Karaaslan, et al.. (1999). Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet's disease. Rheumatology International. 19(1-2). 11–14. 31 indexed citations
12.
Ertenli, İhsan, Sedat Kiraz, İbrahim C. Haznedaroğlu, et al.. (1999). Circulating thrombopoietin in systemic sclerosis.. PubMed. 26(9). 1939–41. 4 indexed citations
13.
Altun, Bülent, Celalettin Usalan, İbrahim C. Haznedaroğlu, et al.. (1999). Thrombopoietin and thrombospondin in renal allograft recipients. Blood Coagulation & Fibrinolysis. 10(5). 23–138. 6 indexed citations
14.
Haznedaroğlu, İbrahim C., et al.. (1998). Thrombopoietin, interleukin-6, and P-selectin at diagnosis and during post-steroid recovery period of patients with autoimmune thrombocytopenic purpura. Annals of Hematology. 77(4). 165–170. 16 indexed citations
15.
Gürgey, Aytemiz, et al.. (1998). Thrombomodulin levels in Behçet's disease with and without the factor V Leiden mutation. Clinical Rheumatology. 17(3). 186–188. 13 indexed citations
16.
Dağdemir, Ayhan, et al.. (1998). Soluble L-Selectin Increases in the Cerebrospinal Fluid Prior to Meningeal Involvement in Children with Acute Lymphoblastic Leukemia. Leukemia & lymphoma. 28(3-4). 391–398. 12 indexed citations
17.
Özen, Seza, U Saatçi, Ayşı̇n Bakkaloğlu, et al.. (1997). Interleukin-1, -6, and -8 levels in juvenile chronic arthritis. Clinical Rheumatology. 16(2). 173–178. 11 indexed citations
18.
Şimşek, Cem, et al.. (1997). Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis.. PubMed. 92(2). 303–6. 22 indexed citations
19.
Ertenli, İhsan, et al.. (1996). Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis. Rheumatology International. 16(1). 5–8. 18 indexed citations
20.
Oymak, Oktay, Tekin Akpolat, Yunus Erdem, et al.. (1995). Increased erythropoietin response to venesection in erythrocytosic renal transplant patients. International Urology and Nephrology. 27(2). 223–227. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026